1. Doxil®—the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012
2. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura;Cancer Res.,1986
3. EPR: evidence and fallacy;Nichols;J. Control. Release,2014
4. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology;Bertrand;Adv. Drug Deliv. Rev.,2014
5. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle;Miller;Sci. Transl. Med.,2015